Amber Parker, APRN
Adult Health · Somerset, KYNPI 1023525805
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.8% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations.
Across 179 payments — averaging $16.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$572
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$531
- AstraZeneca$466
- Abbott$274
- Merck$201
- Johnson & Johnson$139
- plus $745 from 17 others
What the payments were for
- Food & beverage$2,86298%
- Education$652%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 43 | $572 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 45 | $531 |
| AstraZeneca | 24 | $466 |
| Abbott | 8 | $274 |
| Merck | 11 | $201 |
| Johnson & Johnson | 8 | $139 |
| Pfizer | 6 | $105 |
| Amgen | 6 | $99 |
| Boston Scientific | 4 | $72 |
| Convatec Inc. | 2 | $67 |
| Novo Nordisk | 3 | $56 |
| Lexicon Pharmaceuticals, Inc. | 3 | $53 |
| E.r. Squibb & Sons, L.L.C. | 3 | $50 |
| Boehringer Ingelheim | 2 | $43 |
| Philips North America LLC | 2 | $40 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Baxter Healthcare | 1 | $31 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $17 |
| GSK | 1 | $16 |
| Inspire Medical Systems, Inc. | 1 | $15 |
| Bayer | 1 | $15 |
| Esperion Therapeutics, Inc. | 1 | $14 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $13 |
How this compares
$2,927 in reported general payments places this provider in the 85th percentile of 170 adult health providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 237 | $216,985 |
| EntrestoSacubitril/Valsartan | 134 | $153,008 |
| JardianceEmpagliflozin | 143 | $138,259 |
| LeqvioInclisiran Sodium | 32 | $103,508 |
| XareltoRivaroxaban | 50 | $59,234 |
| FarxigaDapagliflozin Propanediol | 71 | $54,974 |
| Repatha SureclickEvolocumab | 35 | $37,989 |
| BrilintaTicagrelor | 44 | $33,546 |
| Ranolazine ErRanolazine | 133 | $19,298 |
| Praluent PenAlirocumab | 30 | $17,202 |
| Rosuvastatin Calcium | 185 | $2,160 |
| Potassium Chloride | 185 | $1,844 |
| Metoprolol Succinate | 232 | $1,798 |
| ClopidogrelClopidogrel Bisulfate | 171 | $1,663 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 271 | $1,564 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto, Leqvio | $572 | $256,516166 claims |
| PfizerEliquis | $105 | $216,985237 claims |
| Boehringer IngelheimJardiance | $43 | $138,259143 claims |
| AstraZenecaFarxiga, Brilinta | $466 | $88,520115 claims |
| Johnson & JohnsonXarelto | $139 | $59,23450 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 170 adult health providers in Kentucky.
Other adult health in Somerset
- Melissa AkerSomerset$2K
- Carrie Clifford-BennettGeorgetown$730K
- Stephanie FlaspoehlerLouisville$174K
- Kimberly VesselsBrandenburg$58K
- Heidi GalloLouisville$15K
- Amy BakerPaducah$14K
- Joyce JohnsonElizabethtown$12K
- Karen EastridgeLouisville$10K
- Seon Hui BalistrereHopkinsville$8K
- Barbara CarpenterLouisville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.